InvestorsHub Logo
Followers 45
Posts 428
Boards Moderated 0
Alias Born 03/04/2011

Re: freethemice post# 81751

Friday, 06/22/2012 12:00:38 PM

Friday, June 22, 2012 12:00:38 PM

Post# of 346548


FTM,

We are working on 1st line and Pancreatic. Intuitively, we believe as you do that the numbers may be supportive of PPHM effort overall.

Both clinicals are long enrollment periods and non- linear ramp up. If I ever get comfortable with the estimates I will revert back. I have long felt that the "measurement" used in the 1st line NSCLC was flawed and aberrant and that the overall result would revert more to the mean which would be more favorable to PPHM.

Best Regards,
RRdog
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News